---
figid: PMC3975884__1746-1596-9-48-1
figtitle: EGFR associated signaling pathways in lung cancer
organisms:
- Bos taurus
- Oryctolagus cuniculus
- Capra hircus
- Homo sapiens
- Mus musculus
organisms_ner:
- Mus musculus
- Bos taurus
- Oryctolagus cuniculus
- Capra hircus
- Homo sapiens
- Danio rerio
pmcid: PMC3975884
filename: 1746-1596-9-48-1.jpg
figlink: /pmc/articles/PMC3975884/figure/F1/
number: F1
caption: EGFR associated signaling pathways in lung cancer. Phosphorylation, i.e.
  activation of the Epidermal Growth Factor Receptor (EGFR) results in various downstream
  signaling pathways including the JAK-STAT-signaling, KRAS, MAPK and the phosphatidylinositol
  3-kinase (PI3K) related pathway. Extrinsic binding of the Endothelian Growth Factor
  (EGF) to the corresponding Endothelian Growth Factor Receptor (EGFR) leads to phosphorylation
  of EGFR and subsequent activation of phosphatidylinositol 3-kinase (PI3K). PI3K
  signaling results in an activation of Akt and TSC1/TSC2, diminishing its inhibitory
  effect on Rheb (Ras homolog enriched in brain), a major activator of mTOR signaling.
  Disruption of the TSC-complex leads to activation (disinhibition) of mTOR and may
  play a putative pathogenic role in lung cancer pathogenesis. Arrows represent activation;
  bars represent inhibitory effects.
papertitle: Tuberous-sclerosis complex-related cell signaling in the pathogenesis
  of lung cancer.
reftext: Angela Fuchs, et al. Diagn Pathol. 2014;9:48-48.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9085604
figid_alias: PMC3975884__F1
figtype: Figure
redirect_from: /figures/PMC3975884__F1
ndex: 410b18fe-de8e-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3975884__1746-1596-9-48-1.html
  '@type': Dataset
  description: EGFR associated signaling pathways in lung cancer. Phosphorylation,
    i.e. activation of the Epidermal Growth Factor Receptor (EGFR) results in various
    downstream signaling pathways including the JAK-STAT-signaling, KRAS, MAPK and
    the phosphatidylinositol 3-kinase (PI3K) related pathway. Extrinsic binding of
    the Endothelian Growth Factor (EGF) to the corresponding Endothelian Growth Factor
    Receptor (EGFR) leads to phosphorylation of EGFR and subsequent activation of
    phosphatidylinositol 3-kinase (PI3K). PI3K signaling results in an activation
    of Akt and TSC1/TSC2, diminishing its inhibitory effect on Rheb (Ras homolog enriched
    in brain), a major activator of mTOR signaling. Disruption of the TSC-complex
    leads to activation (disinhibition) of mTOR and may play a putative pathogenic
    role in lung cancer pathogenesis. Arrows represent activation; bars represent
    inhibitory effects.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Egf
  - Egfr
  - Pik3r1
  - Kras
  - Src
  - Zhx2
  - Akt1
  - Slc12a3
  - Tsc22d1
  - Tsc1
  - Mdk
  - Tsc2
  - Rheb
  - Mtor
  - EGF
  - EGFR
  - PIK3CB
  - KRAS
  - SRC
  - AKT1
  - TSC1
  - TSC2
  - RHEB
  - MTOR
  - PIK3CA
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - NRAS
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - FGR
  - FYN
  - YES1
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT2
  - AKT3
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - SLC12A3
  - TESC
  - CCL26
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - RHEBP1
  - egf
  - celsr1a
  - egfra
  - kras
  - src
  - stat1b
  - stat4
  - tsc1b
  - tsc2
  - rheb
  - rhebl1
  - mtor
  - Cancer
  - Cardiomyopathy
  - Lung cancer
---
